Ethics of randomized trials in a public health emergency

PLoS Neglected Tropical Diseases

Volumn 12, Issue 5, 2018, Pages

  London, Alex John ^a   Omotade, Olayemi O ^b   Mello, Michelle M ^c   Keusch, Gerald T ^d  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVISORY COMMITTEE; EBOLA HEMORRHAGIC FEVER; EMERGENCY HEALTH SERVICE; EPIDEMIC; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL RESEARCH; NOTE; RANDOMIZED CONTROLLED TRIAL (TOPIC); EMERGENCY MEDICINE; ETHICS; PUBLIC HEALTH;

EMERGENCY MEDICINE; HUMANS; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85047848790     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0006313     Document Type: Note

References (9)

1. National Academies of Sciences, Engineering, and Medicine2017. Integrating clinical research into epidemic response: the Ebola experience. Washington, DC: The National Academies Press. doi: 10.17226/24739 Available from: https://www.nap.edu/read/24739/chapter/1 [Cited June 13, 2017] 28696651
2. National Research Council2011. Animal Models for Assessing Countermeasures to Bioterrorism Agents. Washington, DC: The National Academies Press. https://doi.org/10.17226/13233.
3. Adebamowo C, Bah-Sow O, Binka F, Bruzzone R, Caplan A, Delfraissy JF, et alThe Lancet, 2014;384(9952), 1423–4
4. Freedman B., Equipoise and the Ethics of Clinical Research’, New England Journal of Medicine1987, 317: 141–5. doi: 10.1056/NEJM198707163170304 3600702
5. London AJ, Steinbock Bonnie, 2007. “Clinical Equipoise: Foundational Requirement or Fundamental Error” in Oxford Handbook of Bioethics. (New York: Oxford University Press) pp. 571–596.
6. London AJ, Learning health systems, clinical equipoise and the ethics of response adaptive randomization. Journal of Medical Ethics2017. doi: 10.1136/medethics-2017-104549 29175968
7. Mullard A, Parsing clinical success rates. Nature Reviews Drug Discovery. 2016;15, 447. doi: 10.1038/nrd.2016.136 27357012
8. Goodman J. L., Studying “secret serums”—Toward safe, effective Ebola treatments. New England Journal of Medicine2014;371(12):1086–9doi: 10.1056/NEJMp1409817 25140857
9. Uyeki TM, Mehta AK, Davey RT, JrLiddell AM, Wolf T, Vetter P, et al. Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and Europe. Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med. 2016; 374(7):636–46. doi: 10.1056/NEJMoa1504874 26886522